MICROBOT MEDICAL INC (MBOT) Stock Overview
NASDAQ:MBOT - US59503A2042 - Common Stock
MBOT Key Statistics, Chart & Performance
The current stock price of MBOT is 3.66 USD. In the past month the price increased by 25.34%. In the past year, price increased by 317.76%.
MBOT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.13 | 231.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 58 | 167.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.89 | 158.87B | ||
| SYK | STRYKER CORP | 30.53 | 149.98B | ||
| MDT | MEDTRONIC PLC | 16.8 | 119.16B | ||
| BDX | BECTON DICKINSON AND CO | 13.48 | 55.14B | ||
| IDXX | IDEXX LABORATORIES INC | 53.54 | 51.44B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.49 | 47.52B | ||
| RMD | RESMED INC | 29.01 | 40.56B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.25 | 34.58B | ||
| DXCM | DEXCOM INC | 47.36 | 31.57B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.63 | 26.89B |
Related stock screener links
About MBOT
Company Profile
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Company Info
MICROBOT MEDICAL INC
175 Derby St Bld 27
Hingham MASSACHUSETTS 02043 US
CEO: Harel Gadot
Employees: 20
Phone: 17818753605
MICROBOT MEDICAL INC / MBOT FAQ
What is the stock price of MICROBOT MEDICAL INC today?
The current stock price of MBOT is 3.66 USD. The price increased by 8.61% in the last trading session.
What is the ticker symbol for MICROBOT MEDICAL INC stock?
The exchange symbol of MICROBOT MEDICAL INC is MBOT and it is listed on the Nasdaq exchange.
On which exchange is MBOT stock listed?
MBOT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MICROBOT MEDICAL INC stock?
7 analysts have analysed MBOT and the average price target is 9.18 USD. This implies a price increase of 150.82% is expected in the next year compared to the current price of 3.66. Check the MICROBOT MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MICROBOT MEDICAL INC worth?
MICROBOT MEDICAL INC (MBOT) has a market capitalization of 177.55M USD. This makes MBOT a Micro Cap stock.
How many employees does MICROBOT MEDICAL INC have?
MICROBOT MEDICAL INC (MBOT) currently has 20 employees.
What are the support and resistance levels for MICROBOT MEDICAL INC (MBOT) stock?
MICROBOT MEDICAL INC (MBOT) has a support level at 3.36. Check the full technical report for a detailed analysis of MBOT support and resistance levels.
Should I buy MICROBOT MEDICAL INC (MBOT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MBOT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MBOT, evaluating the profitability, health, valuation and growth aspects
- MICROBOT MEDICAL INC (MBOT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MICROBOT MEDICAL INC (MBOT) Sales and EPS estimates to see what analysts future expectations are.
- MICROBOT MEDICAL INC (MBOT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MICROBOT MEDICAL INC (MBOT) Insider and Institutional Ownership to learn about the owners and their transactions.
- MICROBOT MEDICAL INC (MBOT) Stock Chart to make your own analysis
- MICROBOT MEDICAL INC (MBOT) Latest news and press-releases to stay up to date.
Does MICROBOT MEDICAL INC (MBOT) stock pay dividends?
MBOT does not pay a dividend.
When does MICROBOT MEDICAL INC (MBOT) report earnings?
MICROBOT MEDICAL INC (MBOT) will report earnings on 2025-11-11.
What is the Price/Earnings (PE) ratio of MICROBOT MEDICAL INC (MBOT)?
MICROBOT MEDICAL INC (MBOT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).
What is the Short Interest ratio of MICROBOT MEDICAL INC (MBOT) stock?
The outstanding short interest for MICROBOT MEDICAL INC (MBOT) is 14.73% of its float. Check the ownership tab for more information on the MBOT short interest.
MBOT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MBOT. When comparing the yearly performance of all stocks, MBOT is one of the better performing stocks in the market, outperforming 98.35% of all stocks.
MBOT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MBOT. No worries on liquidiy or solvency for MBOT as it has an excellent financial health rating, but there are worries on the profitability.
MBOT Financial Highlights
Over the last trailing twelve months MBOT reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS increased by 18.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -38.36% | ||
| ROE | -41.86% | ||
| Debt/Equity | 0 |
MBOT Forecast & Estimates
7 analysts have analysed MBOT and the average price target is 9.18 USD. This implies a price increase of 150.82% is expected in the next year compared to the current price of 3.66.